These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20146702)

  • 1. Omeprazole-Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over-the-counter doses of proton pump inhibitors.
    Miner PB; McKean LA; Gibb RD; Erasala GN; Ramsey DL; McRorie JW
    Aliment Pharmacol Ther; 2010 Apr; 31(8):846-51. PubMed ID: 20146702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of 24-hour intragastric acidity with morning dosing of immediate-release and delayed-release proton pump inhibitors in patients with GERD.
    Howden CW; Ballard ED; Koch FK; Gautille TC; Bagin RG
    J Clin Gastroenterol; 2009 Apr; 43(4):323-6. PubMed ID: 18758373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of gastric pH with omeprazole magnesium 20.6 mg (Prilosec OTC) o.m. famotidine 10 mg (Pepcid AC) b.d. and famotidine 20 mg b.d. over 14 days of treatment.
    Miner PB; Allgood LD; Grender JM
    Aliment Pharmacol Ther; 2007 Jan; 25(1):103-9. PubMed ID: 17229225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised clinical trial: efficacy of the addition of a prokinetic, mosapride citrate, to omeprazole in the treatment of patients with non-erosive reflux disease - a double-blind, placebo-controlled study.
    Miwa H; Inoue K; Ashida K; Kogawa T; Nagahara A; Yoshida S; Tano N; Yamazaki Y; Wada T; Asaoka D; Fujita T; Tanaka J; Shimatani T; Manabe N; Oshima T; Haruma K; Azuma T; Yokoyama T;
    Aliment Pharmacol Ther; 2011 Feb; 33(3):323-32. PubMed ID: 21118395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
    Inadomi JM; McIntyre L; Bernard L; Fendrick AM
    Am J Gastroenterol; 2003 Sep; 98(9):1940-4. PubMed ID: 14499769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of four lansoprazole dose levels and one dosage regimen of omeprazole on 24-hour intragastric pH in healthy subjects.
    Timmer W; Ripke H; Kleist P; Ehrlich A; Wieckhorst G; Lücker PW; Fuder H
    Methods Find Exp Clin Pharmacol; 1995 Sep; 17(7):489-95. PubMed ID: 8577212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and therapy of gastroesophageal reflux disease with lansoprazole].
    Bordin DS; Masharova AA
    Eksp Klin Gastroenterol; 2008; (5):85-90. PubMed ID: 19145922
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dosaging of proton pumps inhibitors].
    Brørs O
    Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2397-9. PubMed ID: 16998554
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of three alternative treatment strategies after 8 weeks of proton pump inhibitor therapy for GERD in children.
    Lee JH; Kim MJ; Lee JS; Choe YH
    Arch Dis Child; 2011 Jan; 96(1):9-13. PubMed ID: 20870626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pantoprazole: a proton pump inhibitor with oral and intravenous formulations.
    Devault KR
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):197-205. PubMed ID: 19072410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [All proton pump inhibitors are equally efficacious in standard dosages].
    Hellström PM; Vitols S
    Lakartidningen; 2003 Jun; 100(25):2212-6. PubMed ID: 12872509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of patients with heartburn without endoscopic evaluation: on-demand treatment after effective continuous administration of lansoprazole 15 mg.
    Bigard MA; Genestin E
    Aliment Pharmacol Ther; 2005 Oct; 22(7):635-43. PubMed ID: 16181303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of dexlansoprazole MR on nocturnal heartburn and GERD-related sleep disturbances in patients with symptomatic GERD.
    Fass R; Johnson DA; Orr WC; Han C; Mody R; Stern KN; Pilmer BL; Perez MC
    Am J Gastroenterol; 2011 Mar; 106(3):421-31. PubMed ID: 21224838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trial: the effects of the proton pump inhibitor dexlansoprazole MR on daytime and nighttime heartburn in patients with non-erosive reflux disease.
    Fass R; Chey WD; Zakko SF; Andhivarothai N; Palmer RN; Perez MC; Atkinson SN
    Aliment Pharmacol Ther; 2009 Jun; 29(12):1261-72. PubMed ID: 19392864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Prilosec OTC (omeprazole magnesium 20.6 mg) to placebo for 14 days in the treatment of frequent heartburn.
    Allgood LD; Grender JM; Shaw MJ; Peura DA
    J Clin Pharm Ther; 2005 Apr; 30(2):105-12. PubMed ID: 15811162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of reflux symptoms with over-the-counter proton pump inhibitors: issues and proposed guidelines.
    Haag S; Andrews JM; Katelaris PH; Gapasin J; Galmiche JP; Hunt R; Layer P; Malfertheiner P; Holtmann G
    Digestion; 2009; 80(4):226-34. PubMed ID: 19844107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative dosing for PPI therapy: rationale and options.
    Johnson DA
    Rev Gastroenterol Disord; 2003; 3 Suppl 4():S10-5. PubMed ID: 14671509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the presence of a hiatal hernia affect the efficacy of the reflux inhibitor baclofen during add-on therapy?
    Beaumont H; Boeckxstaens GE
    Am J Gastroenterol; 2009 Jul; 104(7):1764-71. PubMed ID: 19491837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of actual costs in long-term therapy of reflux disease. Use of pantoprazole counts].
    MMW Fortschr Med; 2008 Oct; 150(40):52-3. PubMed ID: 18990887
    [No Abstract]   [Full Text] [Related]  

  • 20. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
    Russo A; Dattilo M
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):312-9. PubMed ID: 9476183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.